Jiangsu Bioperfectus Valuation
| 688399 Stock | 70.20 0.17 0.24% |
At this time, the firm appears to be overvalued. Jiangsu Bioperfectus retains a regular Real Value of USD63.86 per share. The prevalent price of the firm is USD70.2. Our model calculates the value of Jiangsu Bioperfectus from evaluating the firm fundamentals such as Return On Asset of -0.0315, current valuation of 2.23 B, and Return On Equity of -0.0496 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 1.2103 | Enterprise Value 2.2 B | Enterprise Value Ebitda 1.4676 | Price Sales 10.4842 | Enterprise Value Revenue 5.6487 |
Overvalued
Today
Please note that Jiangsu Bioperfectus' price fluctuation is very steady at this time. Calculation of the real value of Jiangsu Bioperfectus is based on 3 months time horizon. Increasing Jiangsu Bioperfectus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Jiangsu Bioperfectus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jiangsu Stock. However, Jiangsu Bioperfectus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 70.2 | Real 63.86 | Hype 70.2 | Naive 60.58 |
The real value of Jiangsu Stock, also known as its intrinsic value, is the underlying worth of Jiangsu Bioperfectus Company, which is reflected in its stock price. It is based on Jiangsu Bioperfectus' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Jiangsu Bioperfectus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Jiangsu Bioperfectus Technologies helps investors to forecast how Jiangsu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jiangsu Bioperfectus more accurately as focusing exclusively on Jiangsu Bioperfectus' fundamentals will not take into account other important factors: Jiangsu Bioperfectus Cash |
|
Jiangsu Bioperfectus Total Value Analysis
Jiangsu Bioperfectus Technologies is presently forecasted to have takeover price of 2.23 B with market capitalization of 4.14 B, debt of 164.76 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Jiangsu Bioperfectus fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.23 B | 4.14 B | 164.76 M |
Jiangsu Bioperfectus Investor Information
About 49.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.21. In the past many companies with similar price-to-book ratios have beat the market. Jiangsu Bioperfectus recorded a loss per share of 2.92. The entity last dividend was issued on the 30th of May 2022. Based on the key indicators related to Jiangsu Bioperfectus' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Jiangsu Bioperfectus Technologies is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Jiangsu Bioperfectus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Jiangsu Bioperfectus has an asset utilization ratio of 10.32 percent. This suggests that the Company is making USD0.1 for each dollar of assets. An increasing asset utilization means that Jiangsu Bioperfectus Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Jiangsu Bioperfectus Ownership Allocation
Jiangsu Bioperfectus Technologies has a total of 56.67 Million outstanding shares. Jiangsu Bioperfectus secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Jiangsu Bioperfectus Profitability Analysis
The company reported the revenue of 403.18 M. Net Loss for the year was (384.39 M) with profit before overhead, payroll, taxes, and interest of 3.35 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Jiangsu Bioperfectus' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Jiangsu Bioperfectus and how it compares across the competition.
About Jiangsu Bioperfectus Valuation
The stock valuation mechanism determines Jiangsu Bioperfectus' current worth on a weekly basis. Our valuation model uses a comparative analysis of Jiangsu Bioperfectus. We calculate exposure to Jiangsu Bioperfectus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Jiangsu Bioperfectus's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 257.7 M | 244.8 M |
Jiangsu Bioperfectus Quarterly Retained Earnings |
|
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |